HUL shares fall over 3% after Q3 earnings. Should you buy, sell or hold?

Shares of Hindustan Unilever (HUL) fell over 3% to the day’s low of Rs 2,487 on Saturday following its December quarter earnings where the fast-moving consumer goods (FMCG) sector bellwether reported disappointing earnings on Friday. The commentary by a couple of brokerages was uninspiring for investors with CITI reiterating an ‘Equal Weight’ rating, while Nuvama trimmed EPS estimates even as it retained a buy stance.

The company posted a net profit growth of a mere 0.6% year-on-year (YoY) to Rs 2,519 crore while missing the ETNow poll estimate of Rs 2,724 crore. Revenue from operations fell 0.3% YoY to Rs 15,188 crore and also trailed estimates of Rs 15,533 crore.

Read More: HUL Q3 Results: PAT rises just 0.6% YoY to Rs 2,519 crore, trails estimate

Here’s what brokerages recommended:

Morgan Stanley: Equal Weight | Target: Rs 2,464

The global brokerage maintains an equal weight on the stock and has cut the target price to Rs 2,464 from Rs 2,502 earlier. The post-earnings stock review note noted urban demand to be higher than rural with the premium segment pushing the mass. Among headwinds, volume growth remains weak at 2%, while pricing turned negative in Q3 and will be in Q4 too, it said. The company’s market share is expected to drop over the next few months and recover to current levels by December 2024, Morgan Stanley added.

Nuvama: Buy | Target: 3,105

Nuvama has maintained a buy view on HUL with a revised target price of Rs 3,105 from an earlier target of Rs 3,210.
HUL posted muted Q3FY24 numbers with flat revenue and PAT down YoY below Nuvama’s estimates. The miss on sales and weak revenue was due to price cuts taken to pass on the benefit of commodity deflation, it said. The domestic brokerage has cut FY24E/25E EPS by 5%/3%.

(You can now subscribe to our ETMarkets WhatsApp channel)

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)

FOLLOW US ON GOOGLE NEWS

Read original article here

Denial of responsibility! Todays Chronic is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – todayschronic.com. The content will be deleted within 24 hours.

Leave a Comment